The results of the buy back are encouraging her to break the dollar. Despite the in-house turmoil, she's worked out very well for holders. GL.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025